A detailed history of Schroder Investment Management Group transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Schroder Investment Management Group holds 909,710 shares of TEVA stock, worth $19.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
909,710
Previous 1,027,310 11.45%
Holding current value
$19.6 Million
Previous $16.7 Million 1.8%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $1.86 Million - $2.23 Million
-117,600 Reduced 11.45%
909,710 $16.4 Million
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $2.22 Million - $3.02 Million
173,645 Added 20.34%
1,027,310 $16.7 Million
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $2.63 Million - $3.55 Million
246,076 Added 40.5%
853,665 $12 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $4.93 Million - $6.46 Million
607,589 New
607,589 $6.34 Million
Q4 2022

Feb 10, 2023

BUY
$7.95 - $9.48 $117,493 - $140,104
14,779 Added 65.98%
37,178 $339,000
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $2.56 Million - $4.46 Million
-373,082 Reduced 94.34%
22,399 $181,000
Q2 2022

Aug 11, 2022

SELL
$7.38 - $10.4 $2.32 Million - $3.26 Million
-313,845 Reduced 44.25%
395,481 $3.14 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $47,637 - $61,025
6,499 Added 0.92%
709,326 $6.65 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $177,054 - $228,378
-22,412 Reduced 3.09%
702,827 $5.63 Million
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $16,500 - $20,044
1,969 Added 0.27%
725,239 $7.06 Million
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $6.85 Million - $8 Million
692,127 Added 2222.42%
723,270 $7.16 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $322,018 - $398,941
31,143 New
31,143 $359,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $12,082 - $19,522
-1,488 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $9,954 - $20,013
1,488 New
1,488 $14,000
Q4 2019

Feb 11, 2020

SELL
$6.53 - $10.72 $1.85 Million - $3.04 Million
-283,811 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$6.16 - $9.6 $1.75 Million - $2.72 Million
283,811 New
283,811 $1.96 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $18.5 Million - $30.2 Million
-1,264,695 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $6.65 Million - $8.1 Million
-315,800 Reduced 19.98%
1,264,695 $27.2 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $9 Million - $13.3 Million
-536,600 Reduced 25.35%
1,580,495 $39.1 Million
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $38 Million - $50.3 Million
-2,280,916 Reduced 51.86%
2,117,095 $36.2 Million
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $20.2 Million - $34.3 Million
-1,796,072 Reduced 29.0%
4,398,011 $83.3 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $95.5 Million - $199 Million
6,194,083
6,194,083 $106 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.